Portage Biotech (PRTG)
(Delayed Data from NSDQ)
$8.72 USD
-1.49 (-14.59%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $8.56 -0.16 (-1.83%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Portage Biotech Inc. [PRTG]
Reports for Purchase
Showing records 1 - 14 ( 14 total )
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
Full-Year Fiscal 2023 Results Reported; Lowering PT to $9
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
Fiscal 2Q23 Financial Results Reported; Modulating PT to $21
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
R&D Update Provided; Several Upcoming Milestones; Modulating PT to $22
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
FY2022 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
Outstanding Minority Interest in iNKT Platform Acquired; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
Slew of Adenosine Pathway-Focused Assets Acquired for Stock; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
ASCO Takeaways; We Look Forward to Additional Data by Year-End; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
R&D Agreement Inked With National Cancer Institute; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
Multiple Datasets Expected This Year; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Portage Biotech Inc.
Industry: Medical - Biomedical and Genetics
An Underrated Immuno-Oncology Platform Firm; Initiating at Buy and $32 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
|